Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
CDKN2A promoter methylation
i
Other names:
CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf, Cyclin-dependent kinase inhibitor 2A
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
1029
Related biomarkers:
Expression
Mutation
CNA
Others
‹
CDKN2A deletion (20)
IKZF1 deletion + CDKN2A deletion (2)
CDKN2A deletion + MTAP deletion (1)
MTAP deletion + CDKN2A deletion + CDKN2B deletion + BAP1 deletion (1)
IKZF1 deletion + CDKN2A deletion + CDKN2B deletion + PAX5 deletion (0)
CDKN2A deletion (20)
IKZF1 deletion + CDKN2A deletion (2)
CDKN2A deletion + MTAP deletion (1)
MTAP deletion + CDKN2A deletion + CDKN2B deletion + BAP1 deletion (1)
IKZF1 deletion + CDKN2A deletion + CDKN2B deletion + PAX5 deletion (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
CDKN2A promoter methylation
Melanoma
CDKN2A promoter methylation
Melanoma
palbociclib
Sensitive: D – Preclinical
palbociclib
Sensitive
:
D
palbociclib
Sensitive: D – Preclinical
palbociclib
Sensitive
:
D
CDKN2A promoter methylation
Gastric Cancer
CDKN2A promoter methylation
Gastric Cancer
abemaciclib
Sensitive: D – Preclinical
abemaciclib
Sensitive
:
D
abemaciclib
Sensitive: D – Preclinical
abemaciclib
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.